Urology specialist Prof. Dr. Gokhan Dr. Gökçe also made important statements about MR-TRUS Fusion, a smart biopsy method with high accuracy and sensitivity in the diagnosis of prostate cancer. Prof. Dr. Gökhan Gökçe stated that prostate cancer becomes benign after the age of 50 and said: “Prostate diseases, the most common disease group in men in the world, are seen as prostate infections at a younger age, while after the age of 50 they are more common for if benign prostatic hyperplasia (BPH) or prostate cancer (Pca) will appear,” he said.
“It’s common in men”
Dr Gökhan Gökçe stated that prostate cancer is common in men and said: “With the rapid aging of the population, we are starting to see more prostate enlargement and especially prostate cancer. Prostate cancer is currently the most common cancer in men and is the second leading cause of death after lung cancer. Therefore, it becomes a very important social and medical problem in the aging society. After age 50, nearly half of men begin to experience urinary problems that affect their quality of life. In the diagnosis of prostate cancer, digital prostate examination and measurement of prostate-specific antigen (PSA) in the blood provide important clinical information. In suspected cases, prostate biopsy is required to make a clear diagnosis.
“Targeted biopsy is performed”
Dr. On why prostate biopsy is done, Gökçe said: “Biopsy is performed by your urologist when a suspicious situation is seen on your prostate exam or when a high level of PSA is detected in your blood, to detect if there is cancer in your prostate gland .. As a result of the biopsy, the characteristic features (location, size, aggression) of the cancer, if any, are also evaluated and the treatment approach is determined in the direction of this information.It is based on the processing of Magnetic Resonance (MR ) images, a diagnostic method that allows examining soft tissues, using special software, and combining them with the Trans Rectal Ultrasonography (TRUS) image, which is a method of creating real-time images of organs in the pelvis Thanks to advanced MR technology, suspicious foci in terms of cancer are highlighted in the prostate After the prostate images obtained during the biopsy from the Prostate MR-TRUS Fusion device are converted into 3D images in the same device, the MR and TRUS images are superimposed and the “fusion” process is performed. The biopsy needle is then guided by a robotic arm using the navigation function in the software to the marked suspicious MR areas and a targeted biopsy is performed. Thanks to this method, cancer foci can be detected more accurately and there is no need for repetitive biopsies.
“With MR-TRUS Fusion biopsy, the diagnosis rate is over 95 percent”
Speaking about the advantages of MR-TRUS Fusion biopsy over classical prostate biopsy, Dr. Gökçe stated that the diagnosis rate with this method is 95 percent, saying, “While biopsy samples are taken from standard regions with the classical method under the guidance of Trans-rectal ultrasound, the MR-TRUS Fusion method, which combines advanced MR images with real -time ultrasound images, produces a three-dimensional map of the prostate and sends the biopsy needle to people with suspected cancer.The cancer rate is 25-30 percent in patients with a normal exam and a high PSA. Classic biopsy can reveal 70-75 percent of the existing diagnose cancers. Depending on the number of pieces taken in the biopsy, the risk of infection and septic complications is high despite preventive measures. With MR-TRUS Fusion biopsy, the diagnosis rate rises to more than 95 percent. In addition, since the MR- TRUS Fusion biopsy is targeted, the number of pieces taken will be smaller and the risk of infectious complications will be lower. MR-TRUS Fusion Biopsy increases the detection rate of clinically important cancers (with a high potential for harm to the patient), especially in patients whose PSA elevation persists and no tumor can be detected in recurrent prostate biopsies. Biopsies are taken by imaging the prostate directly above the skin. Therefore, infection, pain, and bleeding complications seen in standard biopsies do not occur. Other benefits are as follows; It is by far the clearest method of diagnosis. Removal of unnecessary areas from biopsy with targeted biopsies. Obtaining the real image of the prostate with MR and 3D US. Because the breech is not used according to the standard method, the number of side effects is very low. Repeat biopsy rates are very low,” he said.